2.4.0.81040 - Disclosure - Product Discovery, Development and Commercialization Collaborationstruefalsefalse1false falsefalseD2013Q2YTDhttp://www.sec.gov/CIK0001123979duration2013-01-01T00:00:002013-06-30T00:00:001true 1snmx_ProductDiscoveryAndDevelopmentCollaborationsDisclosureAbstractsnmx_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Product Discovery, Development and Commercialization Collaborations2false 2us-gaap_CollaborativeArrangementDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div style="font-size:10.0pt;font-family:Times New Roman;"> 4.              Product Discovery, Development and Commercialization Collaborations   In April 2013, the Company amended and restated the Collaborative Research and Development Agreement with Firmenich dated July 28, 2009, as amended, to extend the collaborative research period through July 2016, subject to limited termination rights. The agreement is focused on discovering novel flavor ingredients intended to modify the sweet flavor of sucrose, fructose or various forms of rebaudioside. The significant deliverables under the agreement are research services and certain license rights. Firmenich will pay an additional non-refundable license fee of $5 million, of which $1 million was paid in the second quarter of 2013 and $3 million was paid in the third quarter of 2013. Firmenich will also pay approximately $13 million in research funding over the three-year extension period from July 2013 through July 2016, payable on a quarterly basis. Because of the proprietary nature of the Company’s technology, the Company has determined that the research services and license rights do not have standalone value and are therefore treated as a combined unit of accounting with development revenues to be recognized ratably over the collaborative research period. The Company may receive up to an additional $7 million based on specific objectives related to new sweet flavor ingredients, with a total of $14.1 million in substantive development milestones available under the amended agreement. Firmenich continues to have obligations for other milestone payments, cost reimbursements and royalty payments under an increased royalty rate structure based upon Firmenich sales of flavor ingredients developed under the collaboration.   During the six months ended June 30, 2012, the Company earned a development milestone of $500,000 related to its Cooling Taste Program. </div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 808 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 07-1 -Paragraph 21 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false0Product Discovery, Development and Commercialization CollaborationsfalseProduct Discovery, Development and Commercialization CollaborationsUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.senomyx.com/role/DisclosureProductDiscoveryDevelopmentAndCommercializationCollaborations12